Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease
Open Access
- 1 January 2014
- journal article
- review article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 4 (1), 16
- https://doi.org/10.1186/2045-7022-4-16
Abstract
The type of allergic sensitization is of central importance in the diagnosis and treatment of respiratory allergic diseases. At least 10% of the general population (and more than 50% of patients consulting for respiratory allergies) are polysensitized. Here, we review the recent literature on (i) the concepts of polysensitization, paucisensitization, co-sensitization, co-recognition, cross-reactivity, cross-sensitization, and polyallergy, (ii) the prevalence of polysensitization and (iii) the relationships between sensitization status, disease severity and treatment strategies. In molecular terms, clinical polysensitization can be divided into cross-sensitization (also known as cross-reactivity, in which the same IgE molecule binds to several allergens with common structural features) and co-sensitization (the simultaneous presence of different IgEs binding to allergens that may not necessarily have common structural features). There is a strong overall association between sensitization in skin prick tests and total IgE values but there is debate as to whether IgE thresholds are useful guides to the presence or absence of clinical symptoms in individual cases. Molecular information from component-resolved techniques appears to be of value for diagnosis and treatment decisions. Polysensitization develops over time and is a risk factor for respiratory allergy (being associated with disease severity) and therefore has clinical relevance for treatment decisions. The subterm polysensitization has been defined as polysensitization to between two and four allergens. Polyallergy is defined as clinically confirmed allergy to two or more allergens. Single-allergen grass pollen allergen immunotherapy (AIT) is safe and effective in polysensitized patients, whereas multi-allergen AIT requires more supporting evidence. Given that AIT may be more efficacious in moderate-to-severe disease than in mild disease, polysensitization could be an indication for this type of treatment. There is a need for flowcharts or decision trees for choosing the allergens for AIT in polysensitized patients and polyallergic patients.Keywords
This publication has 47 references indexed in Scilit:
- Component-Resolved Diagnosis in PediatricsISRN Pediatrics, 2012
- How molecular diagnosis can change allergen‐specific immunotherapy prescription in a complex pollen areaAllergy, 2012
- One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questionsAllergy, 2012
- Sensitization patterns to food and inhalant allergens in childhood: A comparison of non‐sensitized, monosensitized, and polysensitized childrenPediatric Allergy and Immunology, 2011
- GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in EuropeAllergy, 2009
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Allergenic Extracts for Specific Immunotherapy: To Mix or Not to Mix?International Archives of Allergy and Immunology, 2006
- The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA2LEN)Allergy, 2005
- Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic childrenAnnals of Allergy, Asthma & Immunology, 1999